INTRODUCTION {#sec1-1}
============

Varicocele is defined as a dilatation of the pampiniform plexus veins. It is the most common cause of male infertility affecting about 15%--20% of the general population and 35%--40% of men presenting for an infertility evaluation.[@ref1][@ref2][@ref3] Until now, the exact mechanisms that ultimately lead to infertility are not fully understood despite the fact that varicocele pathophysiology has been discussed for close to five decades. The main theories postulate that venous reflux leading to elevated testicular temperature and oxidative stress are the key elements.[@ref4][@ref5] Equally debatable is the actual benefit of interventions although recent evidence indicates that treatment may improve the chance of pregnancy in subfertile couples in whom varicocele is the only abnormal finding.[@ref6][@ref7]

Oxidative stress and elevated sperm DNA fragmentation have been associated with varicocele-mediated infertility.[@ref4][@ref6][@ref7][@ref8][@ref9][@ref10][@ref11] Although sperm with fragmented DNA can fertilize oocytes with apparently similar efficiency to sperm without DNA fragmentation, it has been found that high DNA fragmentation negatively impacts embryo development and may jeopardize pregnancy outcomes in assisted reproductive technology (ART).[@ref12][@ref13] There is fair evidence indicating that surgical repair of clinical varicocele improves sperm parameters, decreases seminal oxidative stress and sperm DNA fragmentation, and increases seminal antioxidants.[@ref6][@ref7][@ref14][@ref15] However, it is unclear whether performing varicocelectomy in infertile males with clinical varicocele prior to ART improves treatment outcomes.[@ref16]

The objective of this study was to collect and summarize all evidence that evaluated the benefit of varicocelectomy on ART outcomes in nonazoospermic infertile men with clinical varicocele.

MATERIALS AND METHODS {#sec1-2}
=====================

We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement to report the results of this review.[@ref17] The study was exempted from Institutional Review Board approval as it did not involve any interventions in humans.

 {#sec2-1}

### Search strategy {#sec3-1}

An exhaustive electronic search was performed using the MEDLINE and EMBASE databases up to April 2015. There were no limits placed on the year of publication, but we restricted the search to articles published in English. We also searched among the references of the identified articles. The search combined relevant terms and descriptors related to varicocele, varicocelectomy, varicocele repair, IVF, ICSI, and ART.

### Eligibility criteria and data extraction {#sec3-2}

This systematic review and meta-analysis included studies comparing ART outcomes of nonazoospermic patients with clinical varicocele who underwent varicocelectomy prior to ART to those without prior varicocele repair. Clinical varicoceles were considered as those diagnosed based on the finding of varicose veins in the spermatic cord either by visual inspection or palpation with or without the aid of the Valsalva maneuver during physical examination with the patient standing.[@ref18] ART was defined as all treatments or procedures that include the *in vitro* handling of both human oocytes and sperm or of embryos for the purpose of establishing a pregnancy. This included *in vitro* fertilization (IVF)/intracytoplasmic sperm injection (ICSI) and embryo transfer.[@ref19] For the purpose of this review, ART did not include assisted insemination (artificial insemination) using sperm from either a woman\'s partner or a donor.

The selection criteria are described in [**Table 1**](#T1){ref-type="table"}. In the first screening, two independent authors (M.R. and S.C.E.) assessed all of the abstracts retrieved from the search and then obtained the full manuscripts of the citations that met the inclusion criteria. These authors evaluated the studies' eligibility and quality, and they subsequently extracted the data. Any discrepancies were solved by agreement and, if needed, they reached a consensus with the third author (A.A.).

###### 

Selection criteria of included studies (PICOS)

![](AJA-18-254-g001)

### Outcome measures {#sec3-3}

The pregnancy rates, both clinical pregnancy and live birth, were the primary outcomes of interest. Secondary outcomes included fertilization rate, implantation rate, and miscarriage rate. Clinical pregnancy was defined as a pregnancy observed sonographically by the visualization of a fetal heartbeat by 7 weeks of gestation. The clinical pregnancy rate was the number of clinical pregnancies expressed per 100 embryo transfers. The live birth rate was defined as the ratio between the number of deliveries resulting in at least one live birth and the number of embryo transfers. Miscarriage was defined as a nonviable clinical pregnancy on ultrasound follow-up until gestational week 20. The implantation rate was defined as the number of gestational sacs observed sonographically divided by the number of transferred embryos. The fertilization rate was defined by the number of two pronuclei zygotes divided by the number of metaphase II oocytes subjected to sperm injections.

### Risk of bias assessment {#sec3-4}

We followed the guidance recommended by the Cochrane Collaboration to assess the risk of bias from the included studies.[@ref20] We evaluated sequence generation, allocation concealment, blinding, and incomplete outcome data for each trial included in the review. A low risk of bias was considered when a judgment of "yes" for all domains was obtained, whereas a high risk of bias was considered when a judgment of "no" for one or more domains was obtained. An unclear risk of bias was defined when an "unclear" judgment in any domain was considered. The quality assessment of the included trials is shown in [**Table 2**](#T2){ref-type="table"}.

###### 

Quality assessment of included trials
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### Analysis {#sec3-5}

We pooled the data of the dichotomous outcomes from the original studies to obtain the odds ratio (OR) for the occurrence of an outcome event and presented their corresponding 95% confidence intervals (CIs). Statistical significance was set at *P* \< 0.05. To quantify statistical heterogeneity, we used the *I*^2^ statistic in order to describe the variations across trials that were due to heterogeneity and not to sampling error. We pooled the outcome data from each study using a Mantel-Haenszel model and applied the fixed-effects model. When the heterogeneity was \>50% (*I*^2^ \> 50%), we applied the random-effects model.[@ref21] We used the Review Manager 5 software (Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014) to conduct the meta-analysis. It was not possible to perform a meta-analysis for implantation, miscarriage, and fertilization rates due the nature of the studies evaluating these outcomes.

RESULTS {#sec1-3}
=======

Our electronic search retrieved 114 articles. After screening the titles and abstracts, we determined that six articles were eligible for inclusion. Among these, two articles were excluded. One of them was a review article,[@ref22] and the other study did not fulfill the inclusion criteria[@ref23] as the primary comparison was between patients submitted to varicocelectomy and observation. Although the authors of this aforementioned study evaluated ART outcomes in patients who did not achieve natural pregnancy after varicocele repair, they have included intrauterine insemination as an ART treatment modality. As stated in the eligibility criteria, the objective of our study was to compare only patients submitted to ART as per the ICMART definition. The complete selection process is depicted in [**Figure 1**](#F1){ref-type="fig"}.

![Flowchart showing the identification and selection process of studies included in the meta-analysis.](AJA-18-254-g003){#F1}

 {#sec2-2}

### Description of the included studies {#sec3-6}

Four retrospective studies were included, all of which involved ICSI as the ART method.[@ref2][@ref24][@ref25][@ref26] The four included studies accounted for 870 ICSI cycles (438 with prior varicocelectomy, and 432 without prior varicocelectomy). In three of the included studies, the patients subjected to varicocelectomy had undergone microsurgical subinguinal varicocele repair.[@ref24][@ref25][@ref26] The characteristics of the studies included in this review are presented in [**Table 3**](#T3){ref-type="table"}. Only two of the studies provided information about the interval between varicocelectomy and ICSI.[@ref24][@ref26] In the study by Esteves *et al*., the mean interval between the operation and ART was 6.2 months (range 4 to 13) while it was 7.2 ± 2.8 months in the study by Gokce *et al*.[@ref24][@ref26] Two of the studies stated that only patients without varicocele recurrence were enrolled in the analysis.[@ref24][@ref25] As far as the varicocele grade is concerned, none of the included studies analyzed the association between varicocele grade and ART outcomes.

###### 

Characteristics of the included studies
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### Outcomes {#sec3-7}

[Clinical pregnancy rate]{.ul}

All four included studies reported data on clinical pregnancy ([**Table 4**](#T4){ref-type="table"}).[@ref2][@ref24][@ref25][@ref26] There was a statistically significant increase in the pregnancy rate in three of the studies, favoring the group with prior varicocelectomy.[@ref2][@ref24][@ref26] In one of the studies, the authors did not find a statistically significant difference between the groups with and without previous varicocele repair.[@ref25] Overall, there was a significant increase in the clinical pregnancy rate by ICSI with prior varicocelectomy compared with nonvaricocelectomy (OR = 1.59, 95% CI: 1.19--2.12,*I*^2^ = 25%) ([**Figure 2**](#F2){ref-type="fig"}).

###### 

ICSI outcome in infertile men with treated and untreated clinical varicocele
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![Forest plot of comparison: 1 Varicocelectomy + ICSI versus ICSI without varicocelectomy, outcome: Clinical pregnancy.](AJA-18-254-g006){#F2}

[Live birth rate]{.ul}

Three of the included studies reported data on live birth.[@ref2][@ref24][@ref26] All of them reported statistically increased live birth rates in the group of patients that have undergone varicocelectomy prior to the ICSI procedure ([**Table 4**](#T4){ref-type="table"}). A significant benefit on live birth rates was found for varicocelectomy plus ICSI compared to ICSI without previous varicocelectomy (OR = 2.17, 95% CI: 1.55--3.06, *I*^2^ = 0%) ([**Figure 3**](#F3){ref-type="fig"}).

![Forest plot of comparison: Varicocelectomy + ICSI versus ICSI without varicocelectomy, outcome: Live birth.](AJA-18-254-g007){#F3}

[Implantation rate]{.ul}

Only one of the included studies evaluated implantation.[@ref25] It was observed that the implantation rate was not statistically different in the group subjected to varicocelectomy (17.3%) compared to the one without varicocelectomy (22.1%) ([**Table 4**](#T4){ref-type="table"}).

[Miscarriage rate]{.ul}

There were three studies evaluating miscarriage.[@ref24][@ref25][@ref26] One of them found that the chance of miscarriage was decreased (OR: 0.433; 95% CI: 0.22-0.84) after varicocele was treated.[@ref24] Two of them did not find statistically significant differences between the two groups ([**Table 4**](#T4){ref-type="table"}).[@ref25][@ref26]

[Fertilization rate]{.ul}

Three of the included studies evaluated fertilization after sperm injections. Esteves *et al*. found statistically significant differences between the two groups (78% *vs* 66%, *P* = 0.04), favoring the group with prior varicocelectomy.[@ref24] In contrast, Pasqualotto *et al*.[@ref25] found statistically significant differences between the two groups (64.9% *vs* 73.2%, *P* = 0.03), favoring the group without varicocele repair. Finally, Shiraishi *et al*.[@ref2] did not find statistically significant differences between the two groups (70.3% *vs* 68.6%).

DISCUSSION {#sec1-4}
==========

To our knowledge, this is the first systematic review and meta-analysis addressing the potential benefits of varicocelectomy on ART outcomes in nonazoospermic infertile men with clinical varicocele. Our study included only nonazoospermic patients with clinical varicocele who either underwent or did not undergo varicocelectomy prior to ICSI. Our electronic search did not retrieve any study that evaluated conventional IVF as the ART treatment method. Our findings, which included 870 ICSI cycles, indicated that varicocelectomy prior to ICSI resulted in significantly higher pregnancy rates compared to ICSI without varicocele repair. All included studies reported data on clinical pregnancy, and there was a significant increase in the clinical pregnancy rate with varicocelectomy compared with nonvaricocelectomy (OR = 1.59, 95% CI: 1.19--2.12, *I*^2^ = 25%). Three of the four included studies evaluated live birth rates, and a statistically significant increase in live birth rates was also observed in patients with clinical varicocele subjected to microsurgical varicocelectomy prior to ICSI (OR = 2.17, 95% CI: 1.55--3.06, *I*^2^ = 0%).

Although ICSI is an efficient treatment modality for severe male factor infertility, including varicocele as the underlying cause, the procedure does not take into account for the possibility that the selected spermatozoa have damaged DNA.[@ref12] Sperm DNA fragmentation has been associated with poorer results in ART treatment[@ref27][@ref28][@ref29][@ref30][@ref31][@ref32] though this association is not conclusive.[@ref33][@ref34][@ref35] The results of a recent meta-analysis showed a significant decrease in pregnancy using sperm with high DNA damage in IVF cycles, whereas there was no difference in pregnancy rates in ICSI cycles.[@ref36] These differences might be explained by inherent distinction in the population treated and sperm handling techniques used by IVF and ICSI methods,[@ref37] and reinforce the importance of performing further investigation to evaluate the correlation between sperm DNA damage and IVF/ICSI outcomes.

Despite the fact that none of the included studies had evaluated sperm functional factors, an improvement in sperm function would be a plausible explanation for the observed beneficial effect of prior varicocelectomy on ICSI outcomes. Of note, three of the included studies reported semen analysis results, and in two of them, a significant improvement in sperm count and motility was observed after varicocelectomy.[@ref24][@ref26] It has been shown that patients with a postoperatively improved semen quality are more likely to achieve natural conception after varicocelectomy.[@ref6] In addition, varicocele repair may allow a couple with severely impaired semen parameters to improve and eventually pursue less invasive treatment modalities.[@ref5] Finally, the surgical repair is associated with improvements in functional factors, such as seminal oxidative stress and sperm DNA integrity, which are not routinely assessed in the standard semen analysis.[@ref38][@ref39]

There is increasing evidence suggesting that sperm DNA fragmentation is associated with miscarriage in ART.[@ref13][@ref36][@ref40] In a meta-analysis involving 2969 couples, the risk of miscarriage was increased by 2.16-fold when semen specimens with an abnormally high proportion of DNA damage were used for ICSI (95% CI: 1.54--3.03, *P* \< 0.00001).[@ref13] This increased risk of miscarriage would be related to a "late paternal effect" during the activation of male gene expression.[@ref41] This means that despite nonapparent peri-fertilization, the influence of a damaged paternal chromatin could be observed after zygotic transcriptional activation.[@ref42] In our study, three of the four included series had evaluated miscarriage rates. One of them had found lower chance of miscarriage in the group with prior varicocelectomy when compared to the group without varicocelectomy.[@ref24] Two of the studies did not find statistically significant differences between the two groups. However, one of these studies[@ref26] had included young female patients in whom the negative effect of sperm DNA damage on embryo development might have been modulated by the ability of the oocyte to repair sperm DNA damage before the first cleavage.[@ref42][@ref43][@ref44] In the other, a group of patients with large palpable varicoceles was studied, but surprisingly enough, semen parameters in these patients were very well preserved before varicocele repair, which might have limited the beneficial effect of varicocelectomy.[@ref25]

There are some limitations in our study as there are no randomized clinical trials concerning the research question. All of the included studies were retrospective. Therefore, the quality of this evidence is considered low to moderate. In addition, there is limited objective evidence related to the potential benefits of performing prior varicocelectomy as none of the included studies evaluated functional semen analysis, such as sperm DNA fragmentation. Despite that, a postoperative improvement in conventional semen parameters was noted in two of the included[@ref24][@ref26] In addition, the literature is scarce in studies evaluating the cost-effectiveness of performing microsurgical varicocelectomy prior to ART in nonazoospermic infertile men with clinical varicocele.[@ref45] Thus, it is not possible to conclude whether the increased cost of performing varicocelectomy would be cost-effective for achieving a live birth in this category of infertile men requiring ART.

CONCLUSION {#sec1-5}
==========

The findings of this systematic review and meta-analysis indicate that performing varicocelectomy in patients with clinical varicocele prior to ICSI is associated with improved pregnancy outcomes. The results of our study provide a rationale for conducting further prospective research to evaluate varicocelectomy in infertile men with clinical varicocele before performing ART treatment.
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